Powering Your Path to Transformative Gene Therapies
We’re tackling the complexities of gene therapy manufacturing so you can deliver the transformative.
mission
Our Mission is Your Success
Our mission is to enable access to life-changing therapies by helping to bring them from concept to reality. That means delivering better, more comprehensive AAV manufacturing services, technologies, and infrastructure so gene therapy developers can deliver more therapies to more patients. Period.
values
The Values That Guide Us
Our core values of HOPE–hardworking, open, purpose-driven, and engaged – shape how we work and guide every action we take to deliver on our mission.
Who We Are
We’re a US-based gene therapy CDMO delivering innovative manufacturing solutions designed to guide your therapy from early development through clinical trials and into commercial production.
Part of Ajinomoto Group
Forge is a proud subsidiary of the Ajinomoto Group, supported by the global scale and strength of a company with a longstanding legacy in scientific innovation, commercial excellence, and a steadfast commitment to improving the health of humankind.
See How Our Journey Was Built to Serve Yours
our history
For Gene Therapy Developers, by Gene Therapy Developers
Forge was founded by gene therapy developers who set out to solve the very challenges they once faced. By combining firsthand development experience with deep AAV manufacturing expertise, we built Forge to be a true partner, equipped with the facility, technologies, services, and team to take your program from idea to impact. Explore the milestones that shaped who we are today and where we’re headed together.
Proud to Work Alongside Industry Leaders
Advancing treatments for patients takes a collective effort, and we’re proud to collaborate with gene therapy partners, industry leaders, and trade organizations to move the field forward. Here are a few of the groups helping make it possible.
Our Organizational Leadership
Your programs deserve the best. Meet the leaders behind Forge’s nearly 400 experts dedicated to accelerating your impact.
Scientific & Manufacturing Advisory Board
Our independent board of industry leaders brings deep gene therapy expertise, guiding our focus on development and manufacturing innovation so we can equip your programs with the best tools for success.
.jpg)
Steven J. Gray, Ph.D.
UT Southwestern
.jpg)
Robert Kotin, Ph.D.
Stealth Newco
Karen Kozarsky, Ph.D.
Vector BioPartners
Maritza McIntyre, Ph.D.
Advanced Therapies Partners LLC
.jpg)
Simon Waddington, Ph.D.
University College, London
